Eligibility for medical treatments will be determined by your healthcare provider, who will exercise discretion regarding your treatment plan
Silva will consider your medical history, goals, previous GLP-1 experience, side effects, treatment response, and budget before recommending a treatment plan
The guidance is in response to recent case reports and large case series that have shown a risk of retained gastric contents and cases of pulmonary aspiration during sedation for endoscopic procedures or general anaesthesia in individuals treated with GLP-1RAs or GLP-1/GIPRAs
defined as unstable angina, myocardial infarction, or coronary artery procedures or surgeries) and composite cerebrovascular events (defined as the first occurrence of stroke, transient ischaemic attack, cerebral infarction, carotid intervention or surgery), and the secondary outcome was all-cause mortality